(Q40171023)

18 September 2017

1 reference

title

Possible treatment of pre-eclampsia with calcium channel blocking agents (English)

1 reference

18 September 2017

0 references

G. M. Zaret

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6366485

9 October 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6366485

9 October 2023

publication date

1 December 1983

1 reference

full work available at URL

18 September 2017

https://api.elsevier.com/content/article/PII:0306987783901032?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

https://api.elsevier.com/content/article/PII:0306987783901032?httpAccept=text/plain

9 October 2023

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

9 October 2023

1 reference

18 September 2017

volume

12

1 reference

18 September 2017

issue

4

1 reference

18 September 2017

page(s)

303-319

1 reference

Maternal mortality rates in eclampsia

18 September 2017

cites work

5

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Perinatal mortality and morbidity associated with eclampsia

9 October 2023

6

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Fetal outcome in hypertensive disorders of pregnancy

9 October 2023

7

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Fetal death in eclampsia: I. Its relation to low gestational age, retarded fetal growth and low birthweight

9 October 2023

8

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Causes of perinatal death associated with gestational hypertension and proteinuria

9 October 2023

9

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Abnormalities in infants of mothers with toxemia of pregnancy

9 October 2023

10

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Eclampsia: the remote prognosis

9 October 2023

11

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Hematologic considerations of pregnancy-induced hypertension

9 October 2023

14

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

The indicence of severe pre-eclampsia amongst mothers and mothers-in-law of pre-eclamptics and controls.

9 October 2023

16

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Possible immunologic bases of preeclampsia/eclampsia

9 October 2023

17

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Immunology of pre-eclampsia

9 October 2023

18

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Decrease prostacyclin production: a characteristic of chronic placental insufficiency syndromes

9 October 2023

19

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Production of experimental toxemia in the pregnant rabbit

9 October 2023

20

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

A simplified technique to produce toxemia in the pregnant dog

9 October 2023

21

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Experimental toxemia in the pregnant primate

9 October 2023

23

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Morphologic evidence for coronary artery spasm in eclampsia

9 October 2023

25

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Endothelial changes induced by arterial spasm

9 October 2023

26

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Vascular reactivity to angiotensin II in human pregnancy

9 October 2023

27

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Control of vascular responsiveness during human pregnancy

9 October 2023

28

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Pressor response to angiotonin in pregnant and nonpregnant women

9 October 2023

29

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

VASCULAR REACTIVITY TO ANGIOTENSIN II AND NOREPINEPHRINE IN PREGNANT WOMEN

9 October 2023

30

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

A study of angiotensin II pressor response throughout primigravid pregnancy

9 October 2023

32

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

The value of the angiotensin sensitivity test in the early diagnosis of hypertensive disorders in pregnancy

9 October 2023

33

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Further observations on the nature of pressor responsivity to angiotensin II in human pregnancy

9 October 2023

35

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Prostacyclin in pregnancy.

9 October 2023

36

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Prostacyclin production during pregnancy: comparison of production during normal pregnancy and pregnancy complicated by hypertension

9 October 2023

37

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Effect of Prostaglandin Synthetase Inhibitors on Pressor Response to Angiotensin II in Human Pregnancy*

9 October 2023

38

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Modification of vascular responsiveness to angiotensin II in pregnant women by intravenously infused 5α-dihydroprogesterone

9 October 2023

39

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Reduction of fetal vascular prostacyclin activity in pre-eclampsia.

9 October 2023

40

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Prostacyclin activity in amniotic fluid in pre-eclampsia

9 October 2023

41

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

MATERNAL VASCULAR PROSTACYCLIN ACTIVITY IN PRE-ECLAMPSIA

9 October 2023

42

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Reduced prostacyclin production in pre-eclampsia

9 October 2023

43

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Prostacyclin and pre-eclampsia

9 October 2023

44

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Prostaglandin E2 attenuates the pressor response to angiotensin II in pregnant subjects but not in nonpregnant subjects

9 October 2023

45

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Effects of maternal and fetal plasma from toxemic patients on the vasomotility of the human umbilical artery

9 October 2023

46

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Vasoactive effect of sera from preeclamptic patients

9 October 2023

47

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Oral administration of theophylline to modify pressor responsiveness to angiotensin II in women with pregnancy-induced hypertension

9 October 2023

48

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Management of pregnancy-induced hypertension in the nulliparous patient remote from term

9 October 2023

49

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Management of severe preeclampsia and eclampsia

9 October 2023

50

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Uteroplacental hemodynamic response to antihypertensive drugs in hypertensive pregnant sheep

9 October 2023

53

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

The metabolic clearance rate of dehydroisoandrosterone sulfate. IV. Acute effects of induced hypertension, hypotension, and naturesis in normal and hypertensive pregnancies

9 October 2023

54

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Current concepts: beta-blockers in pregnancy

9 October 2023

55

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

The effect of diazoxide on uterine blood flow in pregnant sheep

9 October 2023

57

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Diazoxide for the acute control of severe hypertension complicating pregnancy: a pilot study

9 October 2023

58

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Nitroprusside-induced hemodynamic alterations in normotensive and hypertensive pregnant sheep

9 October 2023

59

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Fetal toxicity of nitroprusside in the pregnant ewe

9 October 2023

61

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Possible risk with captopril in pregnancy: some animal data

9 October 2023

62

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

The use of magnesium sulfate in preeclampsia-eclampsia

9 October 2023

63

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Standardized treatment of 154 consecutive cases of eclampsia

9 October 2023

64

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

The effect of magnesium sulfate on anoxia and resuscitation in the neonate.

9 October 2023

66

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Diazepam in Labour: Its Metabolism and Effect on the Clinical Condition and Thermogenesis of the Newborn

9 October 2023

67

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Magnesium and seizure control.

9 October 2023

70

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Effect of Magnesium on Epileptic Foci

9 October 2023

71

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Fetal growth retardation and pre-eclampsia

9 October 2023

72

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Drugs and the heart. III. Calcium antagonists

9 October 2023

75

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Calcium Channel Blocking Agents in the Treatment of Cardiovascular Disorders. Part I: Basic and Clinical Electrophysiologic Effects

9 October 2023

76

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Calcium channel blocking agents in the treatment of cardiovascular disorders. Part II: Hemodynamic effects and clinical applications

9 October 2023

77

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Nifedipine in unstable angina: a double-blind, randomized trial

9 October 2023

78

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Antihypertensive Effect of 4 (-2'-Nitrophenyl)-2, 6-Dimethyl-1, 4-Dihydropyridine-3, 5-Dicarbonic Acid Dimethylester (Nifedipine, Bay-a 1040), a New Coronary Dilator

9 October 2023

79

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Hypotensive action and increased plasma renin activity by Ca2+ antagonist (Nifedipine) in hypertensive patients

9 October 2023

80

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Nifedipine, a new antihypertensive with rapid action

9 October 2023

81

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Acute and chronic effects of nifedipine in arterial hypertension

9 October 2023

82

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Antihypertensive effect of cardiovascular Ca2+-antagonist in hypertensive patients in the absence and presence of beta-adrenergic blockade

9 October 2023

83

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Treatment of hypertension with nifedipine, a calcium antagonistic agent

9 October 2023

84

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

A study on the effects of nifedipine in hypertensive crises and severe hypertension

9 October 2023

85

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Short- and long-term efficacy of a calcium-antagonistic agent (nifedipine) combined with methyldopa in the treatment of severe hypertension

9 October 2023

86

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Treatment of severe hypertension and hypertensive emergency with nifedipine, a calcium antagonistic agent

9 October 2023

87

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. I. Hemodynamic effects

9 October 2023

88

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Verapamil in the treatment of hypertrophic cardiomyopathy

9 October 2023

89

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Oral verapamil for paroxysmal supraventricular tachycardia: a long-term, double-blind randomized trial

9 October 2023

90

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Effect of verapamil in infants with paroxysmal supraventricular tachycardia

9 October 2023

91

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Nifedipine and Raynaud's phenomenon.

9 October 2023

92

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Calcium channel blockers and Raynaud's disease

9 October 2023

93

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Calcium antagonists in exercise-induced asthma

9 October 2023

94

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Inhibition of exercise-induced asthma by a calcium antagonist, nifedipine

9 October 2023

95

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Nifedipine in the treatment of achalasia

9 October 2023

97

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Effects of nifedipine on myometrial activity and lower abdominal pain in women with primary dysmenorrhoea

9 October 2023

98

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Trial of the calcium antagonist nifedipine in the treatment of primary dysmenorrhoea

9 October 2023

99

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Treatment of premature labor with the calcium antagonist nifedipine

9 October 2023

100

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Pathophysiology and treatment of coronary arterial spasm

9 October 2023

102

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Calcium entry blockers and vascular smooth muscle heterogeneity

9 October 2023

103

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Cerebral arterial spasm: part 9. In vitro effects of nifedipine on serotonin-, phenylephrine-, and potassium-induced contractions of canine basilar and femoral arteries

9 October 2023

104

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Cerebral arterial spasm: part 10. Reversal of acute and chronic spasm in dogs with orally administered nifedipine

9 October 2023

105

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Effect of a calcium antagonist on experimental constriction of human brain vessels

9 October 2023

106

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

"Calcium Influx Blockers" and Vascular Smooth Muscle: Do We Really Understand the Mechanisms?

9 October 2023

108

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Magnesium and the regulation of muscle contraction

9 October 2023

109

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Effects and subcellular distribution of magnesium in smooth and striated muscle

9 October 2023

110

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Magnesium ions and contraction of vascular smooth muscles: relationship to some vascular diseases

9 October 2023

111

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Interactions of magnesium and verapamil on tone and contractility of vascular smooth muscle

9 October 2023

113

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Effect of the calcium antagonist nifedipine on uterine blood flow in non-treated and oestradiol-treated rats

9 October 2023

114

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Prenatal diagnosis and therapy of fetal heart rate anomalies: With a contribution on the placental transfer of Verapamil

9 October 2023

115

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

The effects of betamimetic drugs used for tocolysis on the fetal myocardium

9 October 2023

116

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

[Cardiac parameters of the newborn after tocolysis (author's transl)]

9 October 2023

117

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

The Renin-Angiotensin-Aldosterone System, Antidiuretic Hormone Levels and Water Balance Under Tocolytic Therapy with Fenoterol and Verapamil

9 October 2023

118

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Does the administration of the calcium-antagonist verapamil in tocolysis with beta-sympathicomimetics still make sense?

9 October 2023

119

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Deactivation of the uterus during normal and premature labor by the calcium antagonist nicardipine

9 October 2023

120

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Inhibition of myometrial activity by calcium antagonists

9 October 2023

121

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Relaxing effects of Nifedipine on the nonpregnant human uterus in vitro and in vivo

9 October 2023

122

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Relaxant effects of nifedipine on isolated, human myometrium

9 October 2023

123

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

Inhibition of prostaglandin-induced uterine activity by nifedipine

9 October 2023

124

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90103-2

9 October 2023

Identifiers

1 reference

18 September 2017

1 reference